Hugeraw Health Technology Co.,Ltd.

You are here: HomeProductsTamoxifen Citrat

Contact us

  • Company Name: Hugeraw Health Technology Co.,Ltd.
  • Country/region: China
  • Contact Person: Ms.Jane zhang
  • Tel: 86-523-51904695
  • Email:

Tamoxifen Citrat

  • CAS No:10540-29-1 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
    Molecular Structure

    Detailed Description

    Tamoxifen Citrat
    CAS No: 10540-29-1
    Molecular formula: C26H29NO
    Molecular weight: 371.51
    Appearance: White crystalline powder
    Assay: 99% min
    Delivery time: 5-7 business days door to door
    Minimum order: 1gram
    Supply ability: 500-600kg/month
    Quality standard: USP27 Usage: Tamoxifen Citrate is suitable for the treatment of advanced breast cancer and ovarian cancer. Pregnancy category D, pregnant and lactating women disabled. It generally affects in 4 ~ 10 weeks in patients, but the curative effect of metastatic bone lesions may work later. Non hormonal contraception measures should be adopted during treatment .
  • Tamoxifen Citrat
  • Tamoxifen Citrat